Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
- 2 December 2012
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (2), 347-359
- https://doi.org/10.1002/mnfr.201200364
Abstract
Scope Recent data suggest that gut microbiota contributes to the regulation of host lipid metabolism. We report how fermentable dietary fructo‐oligosaccharides (FOS) control hepatic steatosis induced by n‐3 PUFA depletion, which leads to hepatic alterations similar to those observed in non‐alcoholic fatty liver disease patients. Methods and results C57Bl/6J mice fed an n‐3 PUFA‐depleted diet for 3 months were supplemented with FOS during the last 10 days of treatment. FOS‐treated mice exhibited higher caecal Bifidobacterium spp. and lower Roseburia spp. content. Microarray analysis of hepatic mRNA revealed that FOS supplementation reduced hepatic triglyceride accumulation through a proliferator‐activated receptor α‐stimulation of fatty acid oxidation and lessened cholesterol accumulation by inhibiting sterol regulatory element binding protein 2‐dependent cholesterol synthesis. Cultured precision‐cut liver slices confirmed the inhibition of fatty acid oxidation. FOS effects were related to a decreased hepatic micro‐RNA33 expression and to an increased colonic glucagon‐like peptide 1 production. Conclusions The changes in gut microbiota composition by n‐3 PUFA‐depletion and prebiotics modulate hepatic steatosis by changing gene expression in the liver, a phenomenon that could implicate micro‐RNA and gut‐derived hormones. Our data underline the advantage of targeting the gut microbiota by colonic nutrients in the management of liver disease.Keywords
This publication has 47 references indexed in Scilit:
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver diseaseClinical Nutrition, 2011
- Obesity Affects the Liver – The Link between Adipocytes and HepatocytesDigestion, 2010
- Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Hepatic lipid metabolism and non-alcoholic fatty liver diseaseNutrition, Metabolism and Cardiovascular Diseases, 2009
- Enhanced free cholesterol, SREBP-2 and StAR expression in human NASHJournal of Hepatology, 2009
- Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based studyJournal of Hepatology, 2007
- A lipidomic analysis of nonalcoholic fatty liver diseaseJournal of Hepatology, 2007
- Polyunsaturated Fatty Acid Pattern in Liver and Erythrocyte Phospholipids from Obese PatientsObesity, 2007
- Increase in long-chain polyunsaturated fatty acid n−6/n−3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver diseaseClinical Science, 2004